钛基基台修复单颗种植体修复体的临床性能:系统综述与Meta分析
本系统综述与Meta分析评估了钛基基台(TBA)用于单颗种植体修复体的存留率。共纳入6项随机对照试验进行Meta分析,比较TBA与其他基台的存留率(OR 0.74;95% CI: 0.21-2.63;I2 0%;p = .99),并纳入23项前瞻性和回顾性研究进行描述性统计。结果显示,857个使用TBA的单颗种植体修复体在功能负载1年后的估计存留率为98.6%(95% CI: 97.9%-99.4%)。结论认为,使用钛基基台修复的单颗种植体修复体显示出良好的短期存留率。
要点
- 钛基基台修复单颗种植体1年存留率约98.6%。
- TBA与其他基台存留率比较无显著差异(OR 0.74,95% CI 0.21-2.63)。
- 平均随访31.2±16.9个月,短期性能良好。
核心结论
- 使用钛基基台修复的单颗种植体修复体显示出良好的短期存留率。
研究设计与样本
- 系统综述与Meta分析,遵循PRISMA指南,检索PubMed、EMBASE和Cochrane Library(2023年4月16日检索,2023年5月5日更新)。
- 纳入6项随机对照试验进行Meta分析,比较TBA与其他基台的存留率。
- 纳入23项前瞻性和回顾性研究(共857个单颗种植体修复体)进行描述性统计,平均随访31.2±16.9个月。
主要发现
- Meta分析显示TBA与其他基台存留率比较的OR为0.74(95% CI: 0.21-2.63;I2 0%;p = .99)。
- 857个使用TBA的单颗种植体修复体在功能负载1年后的估计存留率为98.6%(95% CI: 97.9%-99.4%)。
关键数值与推荐
- TBA修复体1年存留率98.6%(95% CI: 97.9%-99.4%)。
- TBA与其他基台存留率比较OR 0.74(95% CI: 0.21-2.63;I2 0%;p = .99)。
临床怎么用
- 对于单颗种植体修复,钛基基台可作为短期存留率良好的选择。
- 需结合患者具体情况和长期随访数据综合决策。
局限性
- 纳入研究随访时间较短(平均31.2±16.9个月),缺乏长期数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The aim of this review was to evaluate the survival rates of restorations utilizing titanium base abutments (TBA) for restoring single-unit implant prostheses. MATERIALS AND METHODS: This review was conducted following the preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines. The focus question was: In patients who require the restoration of a single dental implant utilizing a titanium base abutment, what are the determining factors and outcomes relating to implant prosthesis prognosis and survival? A comprehensive search of databases (PubMed, EMBASE, and Cochrane Library) was conducted on 16 April 2023 and updated on 5 May 2023. Randomized clinical trials (RCT), retrospective studies and prospective studies, reporting on the use of TBA for single implant prostheses, were reviewed. A Cochrane collaboration risk of bias assessment analysis was performed for randomized clinical studies, and the Newcastle-Ottawa Scale tool was applied for non-randomized studies. A meta-analysis was performed on clinical trials reporting on survival rates of both TBA and other abutments. Other clinical studies, reporting on TBA only, were included for descriptive statistics. RESULTS: The search provided 1159 titles after duplicates were removed. Six RCTs were included to perform a meta-analysis and compare the survival of the TBA to other abutments [OR 0.74; 95% CI: 0.21-2.63, heterogeneity; I2 0%; p = .99]. Twenty-three prospective and retrospective studies fulfilled the criteria and were included in the meta-analysis after 12 months of function. A total of 857 single implant-supported prostheses fabricated with a TBA were included. TBA abutments have an estimate 98.6% survival rate after 1 year in function (95% CI: 97.9%-99.4%). The mean follow-up period was 31.2 ± 16.9 months. CONCLUSIONS: Single implant prosthesis restored with titanium base abutments showed favourable short-term survival rates.
引用
- Chantler JGM, Evans CDJ, Zitzmann NU, et al. Clinical performance of single implant prostheses restored using titanium base abutments: A systematic review and meta-analysis. Clin Oral Implants Res. 2023. PMID: 37750524. doi:10.1111/clr.14128
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。